Henrik Svanström

5.9k total citations · 1 hit paper
79 papers, 3.8k citations indexed

About

Henrik Svanström is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Henrik Svanström has authored 79 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 19 papers in Surgery and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Henrik Svanström's work include Diabetes Treatment and Management (12 papers), Influenza Virus Research Studies (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Henrik Svanström is often cited by papers focused on Diabetes Treatment and Management (12 papers), Influenza Virus Research Studies (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Henrik Svanström collaborates with scholars based in Denmark, Sweden and United States. Henrik Svanström's co-authors include Björn Pasternak, Anders Hviid, Mads Melbye, Morten Frisch, Ditte Mølgaard‐Nielsen, Peter Ueda, Malin Inghammar, Björn Eliasson, Viktor Wintzell and Christian Jonasson and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Henrik Svanström

75 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

2024 57 citations Björn Pasternak, Viktor Wintzell et al. BMJ profile →

Peers

Countries citing papers authored by Henrik Svanström

Since Specialization

Citations

This map shows the geographic impact of Henrik Svanström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Svanström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Svanström more than expected).

Fields of papers citing papers by Henrik Svanström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Svanström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Svanström. The network helps show where Henrik Svanström may publish in the future.

Co-authorship network of co-authors of Henrik Svanström

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Svanström. A scholar is included among the top collaborators of Henrik Svanström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Svanström. Henrik Svanström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Utilization patterns and determinants of guideline-recommended therapies for acute heart failure in Denmark 2025 ·European Heart Journal Acute Cardiovascular Care ·(unknown), Anders Hviid, Björn Pasternak, Henrik Svanström	0
2	Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data 2024 ·Vaccine ·Jill Dreyfus, Swapna Munnangi, Camilla Bengtsson, (unknown), Rejane Augusta de Oliveira Figueiredo, James H. Stark, (unknown), Mark S. Riddle, Jason D. Maguire, Qin Jiang, (unknown), (unknown), Henrik Svanström, Steven A. Bailey, Mitch DeKoven	0
3	Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study 2023 ·Hepatology ·Arvid Engström, Viktor Wintzell, Mads Melbye, Henrik Svanström, Björn Eliasson, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Anders Hviid, Peter Ueda, Björn Pasternak	31
4	Alcohol related disorders among elite male football players in Sweden: nationwide cohort study 2022 ·BMJ ·Peter Ueda, Björn Pasternak, Henrik Svanström, (unknown), Martin Neovius, Magnus Forssblad, Jonas F. Ludvigsson, Manzur Kader	4
5	Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection 2020 ·Clinical Infectious Diseases ·Malin Inghammar, Henrik Svanström, Marianne Voldstedlund, Mads Melbye, Anders Hviid, Kåre Mølbak, Björn Pasternak	34
6	Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data 2020 ·Clinical Drug Investigation ·Viktor Wintzell, Henrik Svanström, Mads Melbye, Jonas F. Ludvigsson, Björn Pasternak, Martin Kulldorff	6
7	Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study 2019 ·BMJ ·Björn Pasternak, Peter Ueda, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Viktor Wintzell, Mads Melbye, Henrik Svanström	77
8	Association between use of azathioprine and risk of acute pancreatitis in children with inflammatory bowel disease: a Swedish–Danish nationwide cohort study 2019 ·The Lancet Child & Adolescent Health ·Viktor Wintzell, Henrik Svanström, Ola Olén, Mads Melbye, Jonas F. Ludvigsson, Björn Pasternak	26
9	Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation 2018 ·International Journal of Cardiology ·Niklas Worm Andersson, Henrik Svanström, Marie Lund, Björn Pasternak, Mads Melbye	28
10	Concomitant use of statins and macrolide antibiotics and risk of serious renal events: A nationwide cohort study 2018 ·International Journal of Cardiology ·Marie Lund, Henrik Svanström, Björn Pasternak, Anders Hviid, Mads Melbye	1
11	Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study 2018 ·BMJ ·Peter Ueda, Henrik Svanström, Mads Melbye, Björn Eliasson, Ann‐Marie Svensson, Stefan Franzén, Soffia Guðbjörnsdóttir, Kristian Hveem, Christian Jonasson, Björn Pasternak	273
12	Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes 2017 ·New England Journal of Medicine ·Nikolai Madrid Scheller, Björn Pasternak, Ditte Mølgaard‐Nielsen, Henrik Svanström, Anders Hviid	62
13	Use of different types of angiotensin converting enzyme inhibitors and mortality in systolic heart failure 2014 ·International Journal of Cardiology ·Henrik Svanström, Björn Pasternak, Mads Melbye, Anders Hviid	9
14	Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease 2013 ·American Journal of Epidemiology ·Björn Pasternak, Henrik Svanström, Kjeld Schmiegelow, Tine Jess, Anders Hviid	176
15	Ondansetron in Pregnancy and Risk of Adverse Fetal Outcomes 2013 ·New England Journal of Medicine ·Björn Pasternak, Henrik Svanström, Anders Hviid	135
16	Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark 2012 ·BMJ ·Björn Pasternak, Henrik Svanström, Ditte Mølgaard‐Nielsen, Tyra Grove Krause, Hanne‐Dorthe Emborg, Mads Melbye, Anders Hviid	94
17	A collaborative approach to investigating the risk of thrombocytopenic purpura after measles–mumps–rubella vaccination in England and Denmark 2011 ·Vaccine ·Nick Andrews, Julia Stowe, Elizabeth Miller, Henrik Svanström, Kari Johansen, Jan Bonhoeffer, Anders Hviid	29
18	Temporal Data Mining for Adverse Events Following Immunization in Nationwide Danish Healthcare Databases 2010 ·Drug Safety ·Henrik Svanström, Torbjörn Callréus, Anders Hviid	17
19	Antibiotic use and intussusception in early childhood 2009 ·Journal of Antimicrobial Chemotherapy ·Anders Hviid, Henrik Svanström	13
20	Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events 2009 ·Vaccine ·Torbjörn Callréus, Henrik Svanström, Nete Munk Nielsen, (unknown), Palle Valentiner‐Branth, Anders Hviid	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact